Sanara MedTech, Inc. (SMTI)
22.99
+0.27
(+1.19%)
USD |
NASDAQ |
Jun 10, 16:00
22.65
-0.34
(-1.48%)
After-Hours: 20:00
Sanara MedTech SG&A Expense (Quarterly) : 21.88M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 21.88M |
| December 31, 2025 | 20.08M |
| September 30, 2025 | 19.88M |
| June 30, 2025 | 21.55M |
| March 31, 2025 | 21.44M |
| December 31, 2024 | 22.42M |
| September 30, 2024 | 18.99M |
| June 30, 2024 | 18.96M |
| March 31, 2024 | 16.19M |
| December 31, 2023 | 16.34M |
| September 30, 2023 | 13.88M |
| June 30, 2023 | 13.81M |
| March 31, 2023 | 12.97M |
| December 31, 2022 | 14.11M |
| September 30, 2022 | 12.06M |
| June 30, 2022 | 10.43M |
| March 31, 2022 | 9.376M |
| December 31, 2021 | 9.161M |
| September 30, 2021 | 6.920M |
| June 30, 2021 | 6.562M |
| March 31, 2021 | 5.410M |
| December 31, 2020 | 5.070M |
| September 30, 2020 | 5.083M |
| June 30, 2020 | 3.624M |
| March 31, 2020 | 4.906M |
| Date | Value |
|---|---|
| December 31, 2019 | 4.418M |
| September 30, 2019 | 3.316M |
| June 30, 2019 | 2.983M |
| March 31, 2019 | 2.350M |
| December 31, 2018 | 1.968M |
| September 30, 2018 | 1.976M |
| June 30, 2018 | 2.048M |
| March 31, 2018 | 1.654M |
| December 31, 2017 | 1.476M |
| September 30, 2017 | 1.303M |
| June 30, 2017 | 1.146M |
| March 31, 2017 | 1.350M |
| December 31, 2016 | 1.119M |
| September 30, 2016 | 0.9637M |
| June 30, 2016 | 1.936M |
| March 31, 2016 | 0.7464M |
| December 31, 2015 | 0.8125M |
| September 30, 2015 | 0.8236M |
| June 30, 2015 | 0.8681M |
| March 31, 2015 | 0.878M |
| December 31, 2014 | 0.8286M |
| September 30, 2014 | 1.074M |
| June 30, 2014 | 1.013M |
| March 31, 2014 | 0.9132M |
| December 31, 2013 | 2.277M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Intelligent Bio Solutions, Inc. | 2.459M |
| Anteris Technologies Global Corp. | 6.93M |
| 20/20 Biolabs, Inc. | 1.353M |
| FONAR Corp. | 8.373M |
| Quest Diagnostics, Inc. | 504.00M |